1Feliu J,Vicent JM,Garcia-Giron C,et al.Phase Ⅱ study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer.Br J Cancer,2004,91:1758-1762. 被引量：1
2Saigi E,Batiste-Alentorn E,Diaz N,et al.Phase Ⅱ study of weekly irinotecan(CPT-11) associated to protracted oral tegafur(TGF) in previously untreated,advanced colorectal cancer(ACRC).Journal of Clinical Oncology,2005,23:302S. 被引量：1
4Douillard JY,Hoff PM,Skillings J,et al.Multicenter phase Ⅲ study of uracil/tegafur and oral leucovin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.J Clin Oncol,2002,20:3605-3616. 被引量：1
1[1]Raymond E,Faivre S,Woynarowski JM,et al.Oxaliplatin:mechanism of action and antineoplastis activity.Sem Oncol,1998,2:4-12. 被引量：1
2[2]Wiseman LR.Oxaliplatin:a review of its use in the management of Metastatic colorectal cancer.Drugs ＆ Aging,1999,14:459-475. 被引量：1
3[3]Bismuth H,Adam R,Levi F,et al.Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant.Ann Surgery, 1996,224:509-522. 被引量：1
3Jemal As Siegel R. Ward E.et a1. Cancer statistics.2007[J]. CA Cancer J Clin.2007 .57(1) :43-66. 被引量：1
4Grundmann RT. Hermanek P. Merkel S. et al, Diagnosis and treatment of colorectalliver metastases-workflow[J]. Zentralbl Chir.200S .133(3) ,267-84. 被引量：1
5Seki T. Wakabayashi M. Nakagawa T. et al, Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma[J].Cancer.1994. 74(3) : 817-25. 被引量：1
6Grothey A. Sargent D. Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil. irinotecan , and oxaliplatin regardless of whether doublet or single-agent therapy is used first line [J]. J Clin Oncol , 200S. 23 (36) ,9441-2. 被引量：1
7Grothey Av Sargent Ds Goldberg RM.et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin. irinotecan , and oxaliplatin in the course of treatment [J]. J Clin Oncol.2004.22 0): 1209-14. 被引量：1
8Tanaka F. Fukuse T. Wada H. et al. The history. mechanism and clinical use of oral S-fluorouracil derivative chemotherapeutic agents[J]. Curr Pharm Biotechnol.2000 .1(2) : 137-64. 被引量：1
9U eno H. Okusaka T. Ikeda M. et al, Phase II study of 5-1 in patients with advanced biliary tract cancer[J]. Br J Cancer. 2004.91(10):1769-74. 被引量：1
10Neoptolemos JP. Stocken DD. Friess H. et al, A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer [J]. N Engl J Med.2004.350 (12) :1200-10. 被引量：1
